Purpose: Determine cyclin-dependent kinase inhibitor 2A (p16 Ink4a ) and polycomb ring finger oncogene (Bmi1) expression in corneal endothelium samples from different age groups and test whether the expression of p16 INK4a and Bmi1 are associated with endothelial cellular senescence in human cornea. Methods: Samples were selected from an eyebank of healthy human corneal endothelial cells (HCECs). Donor human corneas were divided into three age-groups: age ≤30 years, 30-50 years and ≥50 years. The expression of p16 INK4a and Bmil were analyzed by real-time PCR, immunohistochemistry, and immunofluorescence. Results: Through real-time PCR, we detected less than threefold decreases in Bmi1 expression and greater than fivefold increases in p16 INK4a expression associated with aging. Bmi1 expression was significantly down-regulated with increasing donor age. The number of p16 INK4a -positive cells was significantly higher and the number of Bmi1-positive cells was significantly lower in older donors compared to the younger age groups. Our immunohistochemistry experiments showed that the expression of p16 INK4a in older donors was stronger than that in younger donors and the expression of Bmi1 in older donors was weaker than that in younger donors. Results from both the immunohistochemistry and real-time PCR experiments confirmed increased expression of p16 INK4a and decreased expression of Bmi1 with age in HCECs. Additionally, the results of immunofluorescence double-staining for p16 INK4a and Bmi1 further validated the immunocytochemistry and real-time PCR results. Conclusions: Our data are the first to demonstrate that high expression of p16 INK4a and low expression of Bmi1 are associated with endothelial cellular senescence in human cornea. Our findings are not just for cornea transplantation but also for a better understanding of the cornea senescence and the process of aging in this sepcific human organ.
In clinics, the evaluation of the quality of donor corneas is very important for corneal transplantation. In particular, the evaluation of the donor cornea is heavily dependent on the evaluation of human corneal endothelial cells (HCECs). Although the significance of cyclin-dependent kinase inhibitor 2A (p16
Ink4a
) in cell senescence in most tissues is known, its importance in HCECs unknow. The quality of donor corneal endothelial cells is very important for transplant success. Studies in model organisms have suggested that the long-term persistence of donor-derived endothelial cells may be a necessary condition for graft transparency and long-term survival [1] [2] [3] . Due to the lack of proliferative capacity of these cells in vivo, the importance of donor corneal endothelial cell health in corneal transplantation is generally agreed upon. The fact that a significant number of corneas from elderly donors maintain excellent function for a prolonged period of time suggests that biologic age rather than chronological age determines corneal quality and long-term functionality after transplantation. Pioneering work has shown that HCECs are arrested in the G1 phase of the cell cycle and do not proliferate Correspondence to: Ye Wang, Ph.D., Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Qingdao, 266071, PR China; Phone: (086) 0532-85877223; FAX: (086) 0532-85891110; email: wye112002@126.com ex vivo [4] . Due to this relative lack of cell division, human endothelial cell density (ECD) in the normal, healthy cornea decreases with age [5] [6] [7] . The reason remains unclear.
Many studies have shown that cell senescence is closely related to the expression of the inhibitor of cyclin-dependent kinase p16 INK4a [8] [9] [10] [11] ; this inhibitor has received much attention due to its ability to mediate senescence-associated growth arrest [12] [13] [14] , and inhibition of p16
INK4a
plays a decisive role in regulating G1 arrest. In most animal and human tissues, p16
has been shown to markedly increase with aging and can serve as a biomarker of tissue aging [15] [16] [17] . Work in our laboratory has shown an age-related increase in p16 INK4a expression in normal HCECs in vivo [18] . One important pathway involved two cyclin-dependent kinase inhibitors, p16
and cyclin-dependent kinase inhibitor 2A (mouse; p19 Arf ) is regulated by polycomb ring finger oncogene (Bmi1), the first identified polycomb gene family member, which plays important roles in cell cycle regulation, cell senescence, and cell immortalization. The close correlation between down-regulation of p16 INK4a and the upregulation of Bmi1 has been proved in lung cancer and neuroblastoma tumors [19] . Currently there has been no report about the expression of Bmi1 in HCECs. Therefore, in the present study, we aimed to determine Bmi1 expression in corneal endothelium samples from different age groups and Figure 1 . The corneal rims were divided into five parts (A to E). Part A was used for immunofluorescence staining. Part B was stained with trypan blue and alizarin red. The endothelium from part C was stripped away intact and frozen at −80 °C for RNA analysis. Part D and part E were used for the immunohistochemical staining of p16 INK4a and Bmi1, respectively. manufacturer's protocol. Forty-eight hours after transfection, HCECs were collected and lysed using 50 µl of lysis buffer. These expriments were performed in triplicate and repeated at least twice for confirmation.
Real-time quantitative PCR:
Total RNA was isolated according to the manufacturer's protocol (NucleoSpin RNA II System; Macherey-Nagel, Düren, Germany) and subjected to reverse transcription at 42 °C for 60 min in a 40-µl reaction mixture using a first-strand cDNA synthesis kit (BBI, Toronto, ON, Canada). The reagents (TaqMan; Applied Biosystems, Foster City, CA) and sequence detection system (ABI Prism 7500 System; Applied Biosystems) were employed in real-time PCR as recommended by the manufacturer. Each sample was assayed in duplicate (TaqMan Universal PCR Master Mix; Applied Biosystems). The primers and oligonucleotide probes used are listed in Table 2 . Cycling conditions were as follows: 10 min at 95 °C followed by 40 cycles of amplification for 15 s at 95 °C and 1 min at 60 °C. The expected fragment length was between 150 and 300 bp. Quantification data were analyzed with SDS system software (7500 System; Applied Biosystems). The log-linear portion of the fluorescence versus cycle plot was extended to determine a fractional cycle number at which a threshold fluorescence was obtained (threshold cycl [23] ), and this number was used as a reference for each analyzed gene and for glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Immunohistochemistry
and immunofluorescence: Corneal samples were fixed for 10 min in 1 mk of cold (−20 °C) methanol and rinsed three times in phosphatebuffered saline (PBS). The samples were then permeabilized in 1.0% Triton X-100 (Sigma-Aldrich, Shanghai, China) in PBS for 10 min at room temperature, followed by incubation with 5% BSA (Boster Biologic Technology, Ltd., Wuhan, China) in PBS for 10 min at room temperature to block nonspecific binding. For immunohistochemistry, the corneal samples were subjected to staining using the EliVision ™ plus kit (Maxim Corp, Fuzhou, China) according to the manufacturer's protocol. A color reaction was detected using a diaminobenzidine (DAB) kit (Boster Biologic Technology, Ltd.). For immunofluorescence, the corneal pieces were incubated in a mixture of the two primary antibodies at an appropriate dilution for 2 h at room temperature. After the samples were washed in PBS, they were placed in a mixture of two corresponding fluorescence-conjugated secondary antibodies for 30 min at room temperature. The samples were then placed, endothelial side up, on slides in mounting medium containing DAPI for nuclear staining (SigmaAldrich, Shanghai, China). The primary antibodies used were a mouse monoclonal anti-p16 Senescence-associated β-galactosidase (SA-β-Gal) activity staining: SA-β-gal activity staining was performed using SA-β-gal staining kit (Beyotime Institute of Biotechnology, Haimen, China) according to the manufacturer's protocol. Corneal whole mounts were washed with PBS, endothelial cell side up, and fixed with 4% formaldehyde. After washing with PBS (pH 6.0), the tissues were incubated at 37 °C overnight in a humidified chamber with freshly prepared SA-β-Gal staining solution. On the following day, tissues were washed twice in PBS at room temperature for 10 min, and staining was visualized and captured using a microscope equipped with a digital camera (Eclipse e800; Nikon).
Statistical analysis: The differences in numbers of positively stained cells between all age groups were analyzed using a Kruskal-Wallis non-parametric ANOVA, and differences between single age groups were analyzed using the Mann-Whitney U test. The correlation between donor age and the expression of p16
INK4A
was tested using simple linear regression models. R-squared statistics and Pearson correlations were calculated (SPSS software version 12.0; SPSS Inc., Chicago, IL). A p-value of less than 0.05 was considered to be significant.
RESULTS

Regulation of p16
INK4a promoter activity by Bmi1 in HCECs:
The expression of p16 promoter activity increased when Bmi1 was knockdown. However, there was no effect on CMV promoter activity when Bmi1 was overexpressed or knockdown ( Figure 2C,D Figure  3A shows the expression of p16
INK4a
normalized to GAPDH and the fold change in gene expression. There was a statistically significant difference in p16 INK4a expression between the donors younger than 30 years and older than 50 years of age (p≤0.001). Antigen identified by monoclonal antibody Ki-67 (Ki67) is a cellular marker that is closely associated with cell proliferation. We also detected the expression of Ki-67 in HCECs, and there was a statistically significant difference between the donors younger than 30 years and older than 50 years of age (p≤0.001). Representative results of our immunohistochemistry experiments are displayed in Figure 4 . 
Age-dependent upregulation of p16
INK4a is associated with down-regulation of Bmi1: Bmi1 is a member of the polycomb group of transcriptional repressors that was initially identified as an oncogene cooperating with c-myc in a murine lymphoma model [30] . Bmi1 is a negative regulator of p16 INK4a gene expression [31] . To address the question of whether Bmi1 is related to HCECs aging in vivo, we evaluated the expression of Bmi1 by Real-Time PCR. Figure 3 shows the expression of Bmi1 normalized to GAPDH and the fold change in gene expression. There was a statistically significant difference in Bmi1 expression between the donors younger than 30 years and older than 50 years of age. (p≤0.001). By immunohistochemistry, we found that a large number of Bmi1-stained cells were detectable in corneal endothelial cells from donors younger than 30 years of age ( Figure 6A ). In contrast, Bmi1 expression was rarely detectable in corneal endothelium biopsies from donors older than 50 years of age ( Figure 6B) , and the number of Bmi1-positive cells was considerably decreased. Additionally, we found no staining in a negative control ( Figure 6C,D) , indicating that the staining was specific for Bmi1.
Pioneering work has shown that in human skin, the expression of Bmi1 is correlated with p16
INK4a
[16]; therefore we sought to determine whether the expression of Bmi1 is also correlated with p16
in HCECs. We selected three biopsies from each age group for staining for p16 . To further validate our conclusions, we performed immunofluorescence double-staining for p16 INK4a and Bmi1. Figure 5 shows that the fluorescence intensity of p16 INK4a -positive cells (red) in samples from donors older than 50 year of age was stronger than that of samples from donors younger than 30 years of age ( Figure 5A,E) . However, the fluorescence intensity of cells positive for Bmi1 expression (green) in samples from donors older than 50 years of age was lower than that in samples from donors younger than 30 years of age ( Figure 5B,F) . The results of double-staining for p16 INK4a and Bmi1 are displayed in Figure 5D ,H.
For a better understanding of the relationship between cell cycle and two factors in HCEC senescence, doublestaining of p16 INK4a and Bmi1 along with Ki67 in younger and older cases were performed. Figure 8 shows the results of costaining of p16 INK4a and Ki67. The number of p16 INK4a -positive cells in HCECs from old donor were more than that in HCECs from young donor and few Ki67-positive cells were found in HCECs from old donor. Figure 9 shows the results of co-staining of Bmi1 and Ki67. The number and strength of Bmi1-positive cells in HCECs from young donor were higher than that in HCECs from old donor. Besides the expression of p16 INK4a and Bmi1 along with Ki67, we also detected the HCECs senescence using an independent marker such as SA-β-gal activity staining ( Figure 10) . We found few cells that were stained positive for SA-β-gal in HCECs from young donor ( Figure 10A ). However, many SA-β-gal positive cells were found in HCECs from old donor ( Figure 10B ).
DISCUSSION
Here, we have shown that the expression of Bmi1 in HCECs and high expression of p16
INK4a
and low expression of Bmi1 are associated with endothelial cellular senescence in human cornea. HCECs are arrested in early G1 phase in vivo [4, 32, 33] . The reason for this arrest is unknown, but the negative control of the corneal endothelial cell cycle has been found to increase in an age-dependent manner [34] . Compared with our previous report showing an age-related increase in p16 INK4a expression in normal HCECs in vivo [18] , in the present study, we increased the number of samples and expanded the age span investigated and these results were consistent. Findings from our laboratory have demonstrated that in the senescenceaccelerated mouse (SAM), the increased expression of p16
is also an age-dependent phenomenon [35] . In the present study, we have evaluated Bmi1 and p16 In summary, our data strongly support the possibility that p16
can be used as a biomarker for HCECs senescence, as it is used for skin cells [16] and peripheral blood T-cells [15] . Additional studies are required to determine the p16 INK4a expression pattern to elucidate the suitability of donor tissue for corneal transplantation. Our findings are not just for cornea transplantation but also for a better understanding of the cornea senescence and the process of aging in this sepcific human organ.
